DEFA3 belongs to the α-defensins secreted by neurophils, and the preoperative plasma levels of DEFA3 are positively associated with the progression and pathological stages of bladder cancer (Gunes et al., 2013). This evidence concerns the gene DEFA3 and urinary bladder cancer.